FERRONATO-KGS-GROUP
The Swiss technology company FERRONATO KGS GROUP , which specialises in industrial metallised fabrics, forayed into the lifestyle domain with the global launch of a new smart accessories brand – FERRONATO – at the Swiss Pavilion , Expo 2020 Dubai .
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220124005556/en/
"We have always been acknowledged for its focus on innovation tech and the new personal lifestyle accessories brand, Ferronato, is yet another milestone in our journey," said Sandro Giovanni Ferronato, CEO, FERRONATO KGS GROUP LTD.
FERRONATO KGS GROUP was established in 1906 in Lugano, Switzerland. World-renowned for its precision tools, abrasives and metallised fabrics, KGS is now helmed by a 3rd generation, led by Sandro Giovanni Ferronato.
He added, "Ferronato is a lifestyle brand borne out of a sense of immediacy that creates bespoke, high-end accessories that aim to protect your privacy.”
The Ferronato smart accessories showcased at the Swiss Pavilion include a range of personal products powered by KGS metallised fabrics, including laptop sleeves, phone pouches, totes, and briefcases that ensure the protection of privacy and personal information.
The company said the smart accessories made of metallised fabrics fit in well as an antidote to invasive surveillance threats people face at every step of their personal life.
"These smart accessories, made for our digital life, safeguard from several potential digital threats. This includes from stopping tracking of our location, remote activation of our phone to eavesdropping on our conversations to steal critical information and personal data," said Alessia Ferronato, Partner, Ferronato.
KGS said that these accessories will curb hacking, tracking, potential cybercrimes, data theft, digital infiltration and system breeches without the consent of an individual or individuals.
As the world's leading manufacturer of flexible diamond abrasives and electrolytically metallised fabrics, KGS’ industrial products are used across many industry verticals. This includes aerospace, aeronautical, defence, automotive, medical equipment, construction, telecommunications and consumer electronics.
The company, with offices in 16 countries, has been supplying products in over 100 countries from its six manufacturing sites in Switzerland, The Netherlands, Hungary, Portugal, United Arab Emirates, China and India.
For more information, please visit https://www.kgs.swiss/ and https://www.ferronato.swiss/
Instagram: https://www.instagram.com/ferronato.swiss/
Facebook: https://www.facebook.com/ferronato.swiss
*Source: AETOSWire
View source version on businesswire.com: https://www.businesswire.com/news/home/20220124005556/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Making Science Unveils ‘AWAKE’: The AI Venture Studio Industrialising Startup Creation and AI-First Innovative Solutions23.12.2025 20:51:00 CET | Press release
The disruption generated by AI enables the acceleration and industrialisation of the creation of internal solutions and start-ups through centres of excellence in Chicago, Madrid and Tbilisi.This model has already proven its commercial and innovative power through the acceleration of startups like ad-machina, which has multiplied its value by 10 since joining the Making Science ecosystem. Making Science, the global digital acceleration consultancy, today announced the launch of AWAKE Venture Studio. This "AI-first" model represents a new era in systematic innovation, designed to identify, prototype, and scale both internal proprietary solutions and independent AI-native startups with global reach. The launch of AWAKE is motivated by the significant efficiency gains of orders of magnitude that Making Science has already achieved through the internal integration of AI. By applying these methods, the firm has achieved a 2x acceleration in tech feature development reducing time in the depl
FDA Clears First Extended Depth of Focus Contact Lens for Presbyopia23.12.2025 18:07:00 CET | Press release
Deseyne® (vifilcon C) Daily Disposable Soft (Hydrophilic) Contact Lens for Presbyopia with Extended Depth of Focus (EDOF) Delivers Continuous Vision at All Distances—Redefining Presbyopia Correction The Cataltheia Group and its U.S. subsidiary, Bruno Vision Care LLC, a leader in eye health innovation, today announced that the U.S. Food and Drug Administration (FDA) has cleared the first and only Daily Disposable Soft (Hydrophilic) Contact Lens for Presbyopia utilizing patented Extended Depth of Focus (EDOF) optical design technology, enabling commercial distribution in the United States. Deseyne® delivers smooth, continuous focus across near, intermediate, and distance vision, providing clear, natural vision without compromise. This performance is enabled by Cataltheia’s patented hyper-refractive central zone, engineered to precisely redirect light in a controlled manner. The result is a clear clinical advantage over the only other available contact lens option for presbyopia, multifoc
Aramco Awards SLB Long-Term Contract to Support Kingdom’s Unconventional Gas Production Growth23.12.2025 14:58:00 CET | Press release
Five-year contract to drive innovation in stimulation, intervention, digital and frac automationAgreement underscores gas as a pivotal fuel for global energy demand and a bridge to lower-carbon systems Global technology company SLB (NYSE: SLB) has been awarded a five-year contract by Aramco to provide stimulation services for its unconventional gas fields. This award is part of a broader multi-billion contract, supporting one of the largest unconventional gas development programs globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251223074948/en/ The contract encompasses advanced stimulation, well intervention, frac automation, and digital solutions, which are important to unlocking the potential of Saudi Arabia’s unconventional gas resources. The contract encompasses advanced stimulation, well intervention, frac automation, and digital solutions, which are important to unlocking the potential of Saudi Arabia’s unconve
Tabelog, Japan's Largest (*1)Restaurant Search and Reservation Service,Launches Multilingual App for International Visitors23.12.2025 14:00:00 CET | Press release
Experience Japan's Authentic Culinary Scene in Your Language — From Search to Reservation, All on Your SmartphoneRanked No. 1 in Downloads Among "Japanese Gourmet Search Apps" Chosen by International Travelers (*2) Tabelog (https://tabelog.com/en/), Japan's largest restaurant search and reservation service operated by Kakaku.com, Inc., launched its multilingual smartphone application (iOS/Android) for international travelers on Monday, November 17, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251221963753/en/ The Tabelog Multilingual App for International Travelers — Japan's Largest Restaurant Search and Reservation Service With approximately 100 million monthly users(*3), Tabelog is Japan's premier service widely used by Japanese locals for daily restaurant discovery. Its database is unrivaled domestically, featuring information on approximately 890,000 establishments nationwide and over 85 million reviews and photo
BeOne Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference23.12.2025 12:01:00 CET | Press release
BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will participate in the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, with a presentation at 7:30 am PST. Live webcasts of these events can be accessed from the investors section of the Company’s website at https://ir.beonemedicines.com, https://hkexir.beonemedicines.com, https://sseir.beonemedicines.com. Archived replays will be available on the Company’s website. About BeOne Medicines BeOne Medicines is a global oncology company based in Switzerland that is discovering and developing innovative treatments that are more accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of nearly 12,000 colleagues spanning six continents, the Company is committed to
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom